Protein tyrosine kinases in malignant melanoma

Melanoma Research

Volumn 10, Issue 5, 2000, Pages 401-411

  Easty, D J ^a   Bennett, D C ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

EPH A2; FAK; KIT; Melanocyte; Receptor

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; GENE PRODUCT; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR;

CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REVIEW; SIGNAL PROCESSING; VIRUS ONCOGENE;

ANIMALS; HUMANS; MELANOCYTES; MELANOMA; ONCOGENES; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0033773863     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200010000-00001     Document Type: Review

References (123)

1. Oncoprotein networks
2. Signal perception and transduction: The role of protein kinases
3. Receptor protein tyrosine kinases and their signal transduction pathways
4. Regulation of growth factor-induced signaling by protein-tyrosine-phosphatases
5. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
6. Growth factor signaling by receptor tyrosine kinases
7. From Src homology domains to other signaling modules: Proposal of the 'protein recognition code'
8. Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling
9. Signalling networks that cause cancer
10. Ras p21 protein promotes survival and differentiation of human embryonic neural crest-derived cells
11. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a)
12. Apoptosis. A bad kinase makes good
13. Signaling by distinct classes of phosphoinositide 3-kinases
14. Vertebrate non-receptor protein-tyrosine kinase families
15. Signaling through focal adhesion kinase
16. Activation of human pp60c-src
17. Deletion of the c-kit protooncogene in the human developmental defect piebald trait
18. Piebaldism, Waardenburg syndrome and related disorders of melanocyte development
19. Embryonic expression of a haematopoietic growth factor encoded by the S1 locus and the ligand for c-kit
20. Colour genes, oncogenes and melanocyte differentiation
21. Recessive spotting: A linked locus that interacts with W/Kit but is not allelic
22. The PDGF alpha receptor is required for neural crest development and for normal patterning of the somites
23. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes
24. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells
25. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells
26. Characterization of tyrosyl kinase activity in human serum
27. Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro
28. Growth factor independence and growth regulatory pathways in human melanoma development
29. Autocrine and paracrine roles for growth factors in melanoma
30. Protein B61 as a new growth factor: Expression of B61 and upregulation of its receptor epithelial cell kinase during melanoma progression
31. Molecular genetics of human malignant melanoma
32. Malignant melanoma: Modern black plague and genetic black box
33. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2
34. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry, a metallothionein/ret fusion gene
35. Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene
36. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype
37. Met and HGF-SF in normal melanocytes and melanoma cells
38. White mutants in mice shedding light on humans
39. Loss of c-kit expression in cultured melanoma cells
40. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas
41. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor
42. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi
43. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells
44. Spontaneous malignant transformation of melanocytes explanted from W(f)/W(f) mice with a Kit kinase-domain mutation
45. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential
46. Molecular mechanisms of melanoma metastasis
47. Loss of AP-2 results in upregulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells
48. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin
49. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: Demonstration of the relationship to malignant melanoma tumour progression
50. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities
51. Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity
52. Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor
53. The Eph family of receptors
54. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma
55. Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family
56. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
57. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma
58. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes
59. pp125FAK in human melanocytes and melanoma: Expression and phosphorylation
60. Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines
61. Requirement for focal adhesion kinase in tumor cell adhesion
62. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src
63. Signaling through focal adhesion kinase
64. Focal adhesion kinase in integrin-mediated signaling
65. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells
66. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency
67. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors
68. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis
69. Activated ras. Yet another player in melanoma?
70. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
71. Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes
72. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling
73. Expression of gp185HER-2 in human cutaneous melanoma: Implications for experimental immunotherapeutics
74. bFGF as an autocrine growth factor for human melanomas
75. Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization
76. Proliferation of human malignant melanomas is inhibited by anti-sense oligodeoxynucleotides targeted against basic fibroblast growth factor
77. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation
78. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression
79. Stable and strong expression of basic fibroblast growth factor in naevus cell naevus contrasts with aberrant expression in melanoma
80. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma
81. Association of the polyomavirus middle-T antigen with c-yes protein
82. Polyoma middle T abrogates TPA requirement of murine melanocytes and induces malignant melanoma
83. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells
84. Mechanism of c-SRC activation in human melanocytes: Elevated level of protein tyrosine phosphatase activity directed against the carboxy-terminal regulatory tyrosine
85. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn
86. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis
87. Coexpression of transcripts encoding EPHB receptor protein ryrosine kinases and their ephrin-B ligands in human small cell lung carcinoma
88. B61 is a ligand for the ECK receptor protein-tyrosine kinase
89. B61, a ligand for the Eck receptor protein-tyrosine kinase, exhibits neurotrophic activity in cultures of rat spinal cord neurons
90. The Eph family of receptors
91. Epithelial cell kinase-B61: An autocrine loop modulating intestinal epithelial migration and barrier function
92. Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity
93. Upregulation of ephrin-A1 during melanoma progression
94. Overexpression of Lerk-5/Eplg5 messenger RNA: A novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas
95. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein
96. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis
97. The Eph family in the patterning of neural development
98. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma
99. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression
100. Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization
101. Inhibition of growth of primary human tumour cell cultures by a 4-anilinoquinazoline inhibitor of the epidermal growth factor receptor family of tyrosine kinases
102. The melanoma-specific XMEL antigen is expressed in dysplastic naevi
103. Multiple structural elements determine ligand binding of fibroblast growth factor receptors. Evidence that both Ig domain 2 and 3 define receptor specificity
104. Growth factors and melanomas
105. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth
106. Vascular endothelial growth factor
107. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGE
108. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
109. Enhanced expression of vascular endothelial growth factor in metastatic melanoma
110. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors
111. Protein kinases in normal and transformed melanocytes
112. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
113. Vascular endothelial growth factor stimulates tyrosine phosphorylation of FAK and paxillin in endothelial cells
114. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes
115. Tumors: Wounds that do not heal
116. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes
117. Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma
118. Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo
119. Gene expression in melanoma cell lines and cultured melanocytes: Correlation between levels of c-src-1, c-myc and p53
120. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells
121. Mapping of tyrosine kinase gene family members in a xiphophorus melanoma model
122. c-fms is present in tumours as well as in their metastases in bone marrow